BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Noseda ACD, Rodrigues LS, Targa ADS, Ilkiw JL, Fagotti J, Dos Santos PD, Cecon E, Markus RP, Solimena M, Jockers R, Lima MMS. MT2 melatonin receptors expressed in the olfactory bulb modulate depressive-like behavior and olfaction in the 6-OHDA model of Parkinson's disease. Eur J Pharmacol 2021;891:173722. [PMID: 33159932 DOI: 10.1016/j.ejphar.2020.173722] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Li J, Liu H, Wang X, Xia Y, Huang J, Wang T, Lin Z, Xiong N. Melatonin ameliorates Parkinson’s disease via regulating microglia polarization in a RORα‐dependent pathway. npj Parkinsons Dis 2022;8:90. [DOI: 10.1038/s41531-022-00352-5] [Reference Citation Analysis]
2 Jin Z, Han Y, Zhang D, Li Z, Jing Y, Hu B, Sun S. Application of Intranasal Administration in the Delivery of Antidepressant Active Ingredients. Pharmaceutics 2022;14:2070. [DOI: 10.3390/pharmaceutics14102070] [Reference Citation Analysis]
3 Gerbier R, Jockers R. GTPγS Binding Assay for Melatonin Receptors in Mouse Brain Tissue. Melatonin 2022. [DOI: 10.1007/978-1-0716-2593-4_20] [Reference Citation Analysis]
4 Noseda ACD, Lima MMS. Olfaction and Melatonin: The Use of the Olfactory Discrimination Test. Melatonin 2022. [DOI: 10.1007/978-1-0716-2593-4_41] [Reference Citation Analysis]
5 Niyomrat K, Cheaha D, Nukitram J, Kumarnsit E. Locomotor activity and resting local field potential oscillatory rhythms of 6-OHDA mouse model of Parkinson's disease in response to acute and repeated treatments with L-dopa. Neurosci Lett 2021;759:136007. [PMID: 34098022 DOI: 10.1016/j.neulet.2021.136007] [Cited by in F6Publishing: 2] [Reference Citation Analysis]